We can speculate that hesperetin’s anti-inflammatory properties might aid in reducing the inflammation that SFRP4 causes because SFRP4 is associated with low-grade islet inflammation in T2D. The gene discussed is SFRP4; the disease is type 2 diabetes mellitus.